Lyra Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Lyra Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 14% to $1,558,000. Profit margin reached -4023%. Total operating expenses were $68,678,000.
Profit Margin
| 2018 | 1.24M | -6.02M | -484.65% |
|---|---|---|---|
| 2019 | 0 | -16.09M | |
| 2020 | 0 | -22.04M | |
| 2021 | 285K | -42.41M | -14880.7% |
| 2022 | 1.36M | -55.27M | -4055.61% |
| 2023 | 1.55M | -62.68M | -4023.11% |
LYRA Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 1.55M | 1.36M | 285K | 0 | 0 | 1.24M |
Cost of revenue | 0 | 1.06M | 1.00M | 95K | 27K | 0 |
Gross profit | 1.55M | 296K | -715.99K | -95K | -27K | 1.24M |
Operating exp. | ||||||
Research and development | 48.02M | 38.79M | 29.69M | 12.52M | 12.03M | 4.97M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 68.67M | 56.35M | 43.9M | 22.20M | 16.51M | 8.50M |
Operating income | -67.12M | -56.30M | -43.61M | -22.20M | -16.51M | -7.25M |
Other income (expenses), net | 4.49M | 1.04M | 102K | 82K | 213K | 1.19M |
Income before tax | -62.62M | -55.26M | -43.51M | -22.12M | -16.30M | -6.02M |
Income tax expense | 59K | 13K | -1.10M | -82K | -213K | -1.23M |
Net income | -62.68M | -55.27M | -42.41M | -22.04M | -16.09M | -6.02M |
Earnings per share | ||||||
Basic EPS | -1.26 | -1.83 | -3.27 | -2.57 | -1.25 | -0.96 |
Diluted EPS | -1.26 | -1.83 | -3.27 | -2.57 | -1.25 | -0.96 |
| Data source | Data source | Data source | Data source |